Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma. - Wikidata - wikimedia - TriplyDB

Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.

Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.

http://www.wikidata.org/entity/Q37641721

about

MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcoma.Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis.Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

P2860

Q33798537-909F73F0-DB0C-4734-9A9C-A3566166A57C Q38791215-37625456-BFD2-41C2-BD1D-6659892E363D Q38809116-F8B777F1-42E0-4FDD-8966-88EC84C394DE Q41883809-41EB39DE-3123-444A-B17C-4949722657C5 Q55518023-DACF42A3-F0E4-45DB-8ED0-5AC4474781F7 Q57490969-27F99FDA-2D21-453E-B012-57E6E37C0E61

P2860

Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.

http://www.wikidata.org/entity/Q37641721

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Candidate germline polymorphis ...... tatic high-grade osteosarcoma.

@en

Candidate germline polymorphis ...... tatic high-grade osteosarcoma.

@nl

type

label

Candidate germline polymorphis ...... tatic high-grade osteosarcoma.

@en

Candidate germline polymorphis ...... tatic high-grade osteosarcoma.

@nl

prefLabel

Candidate germline polymorphis ...... tatic high-grade osteosarcoma.

@en

Candidate germline polymorphis ...... tatic high-grade osteosarcoma.

@nl

P1433

Q37641721-AA7648D8-F93C-4F2E-8446-9C8019B31CC8

P1476

Q37641721-1A0673D9-CDE2-49A4-B61F-EC7449F8608C

P2093

Q37641721-0B09E81A-09E0-4CF2-8C33-050FD5B76AE2

Q37641721-3EF41D93-AB9A-4C6C-B71F-D9FC3BC09F43

Q37641721-4BAE9A0C-65FA-4926-831C-3F3F49D50150

Q37641721-71847CAF-C2F8-4617-A642-5484C6FD89CF

Q37641721-7205AD09-E3CE-4D53-B301-6403D803C16D

Q37641721-A25E154F-4FCC-448D-9D17-13DBF7DE7438

Q37641721-BFD81D19-3978-4B18-A1DD-98B52DE25AB4

Q37641721-F3AF3044-4D01-4990-8BB1-E3E196DC1CE6

P2860

Q37641721-02995B7F-B6B5-44B1-9B40-FC8B18B1B6F5

Q37641721-171DC663-D47C-4EEB-9814-888329E2D34D

Q37641721-2A932027-FF1C-406C-A19C-26FA8123564D

Q37641721-70D99C82-0EDF-4E20-A503-19B1932CFC47

Q37641721-77BEFF23-BD39-4FB6-9EE3-820AB648F025

Q37641721-7E926CB1-0D64-468F-AFF4-F3B41075DAF5

Q37641721-8723F780-3BD0-409B-977F-5B3A179E653A

Q37641721-8D44ACCB-B00E-40AB-B08F-D7E7B26E539A

Q37641721-914DF815-C0B9-459D-A179-C0060B64E1F5

Q37641721-98CBADFF-FFFE-47BF-B426-8DED037BD81F

P304

Q37641721-4CB0FB1A-7CE2-4F9A-9B47-3335D138ACD9

P31

Q37641721-61F6E9E0-720E-4A77-B116-B4AA398D7DE1

P356

Q37641721-7F2D1EC0-94BF-41AA-B293-E5C765CB6060

P407

Q37641721-BA5DD44F-71D2-4B67-BB5B-0B6D9C656F36

P433

Q37641721-32AEF885-5CB7-45CD-925A-FDDA8EA35788

P478

Q37641721-88C36D52-3898-4E2B-8D58-D3268A8D47D1

P50

Q37641721-03E15873-9423-4BE4-97B9-0C5D0BDC564F

Q37641721-18DA157B-C39C-457C-B4E8-24A6F1E1C7E3

Q37641721-36B48F99-37C9-4031-A4E8-CC2EA45FE0C1

Q37641721-4DA70210-16F4-4E83-8707-6BD935761C23

Q37641721-6104B8C2-3C66-4A73-BA94-24717CB9C2ED

Q37641721-6620B13C-340A-4FF1-81AC-93C1BA375ABE

Q37641721-6EBA6517-F31F-407D-9FFF-7C7A73012BC5

Q37641721-A7B5D38C-E1B5-4E21-AD2B-44CF09AD7273

P577

Q37641721-0406B928-856E-4098-A611-BA46EB46FC52

P698

Q37641721-9CDF56B1-72E2-470A-BD11-97D4EFC10997

P921

Q37641721-37AAF482-9367-4264-A036-CE9EA6A3A37E

P932

Q37641721-A4942E9E-EB2B-4F9D-909E-771B4BD46B81

P356

ONCOTARGET.11486

P1433

P1476

Candidate germline polymorphis ...... tatic high-grade osteosarcoma.

@en

P2093

Andrea Roli

http://www.w3.org/2001/XMLSchema#string

Elisa Tavanti

http://www.w3.org/2001/XMLSchema#string

Erika Iacoboni

http://www.w3.org/2001/XMLSchema#string

Luciana Giodini

http://www.w3.org/2001/XMLSchema#string

Marilù Fanelli

http://www.w3.org/2001/XMLSchema#string

Piero Picci

http://www.w3.org/2001/XMLSchema#string

Serena Vella

http://www.w3.org/2001/XMLSchema#string

Stefano Ferrari

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association study identifies two susceptibility loci for osteosarcoma

Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study

Functional clustering: identifying strongly interactive brain regions in neuroimaging data.

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.

Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations

Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review.

Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.

Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.

PharmGKB summary: methotrexate pathway.

Germline TP53 variants and susceptibility to osteosarcoma.

P304

61970-61987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11486

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Claudia Maria Hattinger

Katia Scotlandi

Rossana Roncato

P577

2016-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27566557

http://www.w3.org/2001/XMLSchema#string

P921

P932

5308704

http://www.w3.org/2001/XMLSchema#string